Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals

被引：11

作者：

Krestova, Michala ^{[1
,2
]}

Hromadkova, Lenka ^{[1
,3
,4
]}

Bilkova, Zuzana ^{[4
]}

Bartos, Ales ^{[1
,2
]}

Ricny, Jan ^{[1
]}

机构：

[1] Natl Inst Mental Hlth, Klecany, Czech Republic

[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic

[3] Charles Univ Prague, Fac Sci, Prague, Czech Republic

[4] Univ Pardubice, Dept Biol & Biochem Sci, Pardubice, Czech Republic

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2017年 / 313卷

关键词：

Alzheimer's disease; Brain homogenates; Plasma antibodies; Reactivity profile; Tau protein; INTRAVENOUS IMMUNOGLOBULIN PRODUCTS; NATURALLY-OCCURRING AUTOANTIBODIES; NEUROFIBRILLARY TANGLES; NEURONAL-ACTIVITY; PATHOLOGICAL TAU; ENDOGENOUS TAU; AMYLOID-BETA; A-BETA; IMMUNOTHERAPY; PROTEIN;

D O I：

10.1016/j.jneuroim.2017.09.011

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The presence of natural tau-reactive antibodies was reported in human blood. In this study, we isolated and characterized natural tau-reactive antibodies occurring in IVIG product Flebogamma, plasma of patients with Alzheimer's disease (AD) and older cognitively normal persons (controls). Using blotting immunoassays and ELISA, we showed reactivity of antibodies obtained from IVIG and controls against a recombinant fragment of tau (155-421 aa) and aggregates present in brains of AD patients. In contrast, antibodies isolated from plasma of AD patients reacted mainly with the recombinant full-length tau form and tau monomeric forms in brain tissue.

引用

页码：16 / 24

页数：9

共 50 条

[41] Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease [J].

Chatterjee, Pratishtha ;

Pedrini, Steve ;

Stoops, Erik ;

Goozee, Kathryn ;

Villemagne, Victor L. ;

Asih, Prita R. ;

Verberk, Inge M. W. ;

Dave, Preeti ;

Taddei, Kevin ;

Sohrabi, Hamid R. ;

Zetterberg, Henrik ;

Blennow, Kaj ;

Teunissen, Charlotte E. ;

Vanderstichele, Hugo M. ;

Martins, Ralph N. .

TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)

[42] Performance of Plasma Phosphorylated tau-217 in Patients on the Continuum of Alzheimer's Disease [J].

Dakterzada, Farida ;

Lopez-Ortega, Ricard ;

Vilella-Figuerola, Alba ;

Montero-Castilla, Nathalia ;

Riba-Llena, Iolanda ;

Ruiz-Julian, Maria ;

Arias, Alfonso ;

Sarto, Jordi ;

Tahan, Nuria ;

Pinol-Ripoll, Gerard .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (14)

[43] Characterization of tau species in plasma as a blood-based detection method for Alzheimer's Disease [J].

Adelzadeh, Bita ;

Adel-Zadeh, Bita ;

Liu, Lei ;

Chhatwal, Jasmeer .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (05)

[44] First-in-human study of blood amyloid β removal from early Alzheimer's disease patients with normal kidney function [J].

Hasegawa, Midori ;

Kitaguchi, Nobuya ;

Takechi, Hajime ;

Kawaguchi, Kazunori ;

Ito, Kengo ;

Kato, Takashi ;

Kato, Masao ;

Nii, Norio ;

Yamada, Sachie ;

Ohashi, Atsushi ;

Koide, Shigehisa ;

Hayashi, Hiroki ;

Takahashi, Kazuo ;

Inaguma, Daijo ;

Yuzawa, Yukio ;

Tsuboi, Naotake .

THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (03) :529-536

[45] Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients [J].

Lilamand, Matthieu ;

Bouaziz-Amar, Elodie ;

Dumurgier, Julien ;

Cognat, Emmanuel ;

Hourregue, Claire ;

Mouton-Liger, Francois ;

Sanchez, Manuel ;

Troussiere, Anne-Cecile ;

Martinet, Matthieu ;

Hugon, Jacques ;

Paquet, Claire .

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2023, 78 (04) :645-652

[46] Epigenome-wide association study of cerebrospinal fluid-based biomarkers of Alzheimer's disease in cognitively normal individuals [J].

Huls, Anke ;

Liu, Jiaqi ;

Konwar, Chaini ;

Conneely, Karen N. ;

Levey, Allan I. ;

Lah, James J. ;

Wingo, Aliza P. ;

Wingo, Thomas S. .

ALZHEIMERS & DEMENTIA, 2025, 21 (06)

[47] Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome [J].

Tatebe, Harutsugu ;

Kasai, Takashi ;

Ohmichi, Takuma ;

Kishi, Yusuke ;

Kakeya, Tomoshi ;

Waragai, Masaaki ;

Kondo, Masaki ;

Allsop, David ;

Tokuda, Takahiko .

MOLECULAR NEURODEGENERATION, 2017, 12

[48] Astrocytic accumulation of tau fibrils isolated from Alzheimer's disease brains induces inflammation, cell-to-cell propagation and neuronal impairment [J].

Eltom, Khalid ;

Mothes, Tobias ;

Libard, Sylwia ;

Ingelsson, Martin ;

Erlandsson, Anna .

ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01)

[49] The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer's Disease [J].

Cheng, Yuan ;

Jian, Jie-Ming ;

He, Chen-Yang ;

Ren, Jun-Rong ;

Xu, Man-Yu ;

Jin, Wang-Sheng ;

Tan, Cheng-Rong ;

Zeng, Gui-Hua ;

Shen, Ying-Ying ;

Chen, Dong-Wan ;

Li, Hui-Yun ;

Yi, Xu ;

Zhang, Yuan ;

Zeng, Fan ;

Wang, Yan-Jiang .

JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (01) :375-383

[50] Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients [J].

Zhao, Qian ;

Liu, Min ;

Ha, Lingxia ;

Zhou, Yun .

FRONTIERS IN NEUROLOGY, 2019, 10

← 1 2 3 4 5 →